Oregon Health And Science University

BOSTON — The majority of people with acromegaly receiving oral octreotide achieve a biochemical response, regardless of their baseline insulin-like growth factor I level, according to data from a post hoc analysis.

Approximately one in 1,000 pregnant women will be diagnosed with cancer, and incidence of pregnancy-associated cancer is on the rise as maternal age increases.

Last autumn, the availability of the 2023-2024 updated COVID-19 vaccines, which more closely targeted the then-dominant XBB omicron subvariant lineage, promised to restore protections that had waned over time.

SAN DIEGO — An intravenous formulation of secukinumab met all primary efficacy endpoints, with an attractive safety profile, in patients with axial spondyloarthritis over 52 weeks, according to data presented at ACR Convergence 2023.

SAN FRANCISCO — Data show a novel transcatheter mitral valve edge-to-edge repair system was associated with a sustained reduction in mitral regurgitation plus functional and quality-of-life gains for patients at prohibitive surgical risk.

Clear communication is an essential component of patient-centered care delivery in the cancer setting.

Incidence of venous thromboembolism remained high among patients with cancer even as the treatment landscape has evolved over the past 16 years, according to data published in JAMA Network Open.

CHICAGO—In this video exclusive, Maria Fleseriu, MD, FACE, and Adina Turcu, MD, MS, talk about research on adrenal disorders presented at ENDO 2023, including artificial intelligence and a debate about which patients to screen for primary aldosteronism.

In this video exclusive, Maria Fleseriu, MD, FACE, reviews the pituitary and adrenal research highlights presented at ECE 2023, the annual meeting of the European Society of Endocrinology, which took place in Istanbul, Turkey, in May.

All immunocompromised adults should receive the high-dose formulation of the influenza vaccine, according to a presenter at the Biologic Therapies Summit.